New hope for Tough-to-Treat lung cancer?
Disease control
Terminated
This study tested whether adding an experimental drug called bemcentinib to standard chemotherapy and immunotherapy is safe and effective for people with advanced non-small cell lung cancer. It focused on patients who had not received prior treatment and included a group with a s…
Phase: PHASE1, PHASE2 • Sponsor: BerGenBio ASA • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC